Incliva participates in the $6.2 million (€5.2 million) European Rebecca project to address the post-treatment of breast cancer. The project will end in March 2025 and...
Frontwave will open a financing round to develop its product. Once the product is certified by clinical trials, the company expects to have a turnover of...
The Spanish biotech company Reveal Genomics has raised funds from a national business angel to carry out two projects addressing breast cancer. This diagnostic test for...